Cellectar Biosciences, Inc. (CLRB) vs Jasper Therapeutics, Inc. (JSPR)
Cellectar Biosciences, Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Jasper Therapeutics, Inc. are of similar size ($19.6M and $19.5M). Across the 8 metrics below, Cellectar Biosciences, Inc. leads on 7 and Jasper Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | CLRB | JSPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (125.99%) | (255.05%) | (57.72%) |
| Return on assets | (88.70%) | (109.05%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack